Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1989 1
1990 3
1991 2
1992 7
1993 6
1994 19
1995 37
1996 55
1997 45
1998 48
1999 68
2000 63
2001 57
2002 54
2003 47
2004 39
2005 30
2006 20
2007 28
2008 21
2009 16
2010 16
2011 19
2012 10
2013 17
2014 14
2015 11
2016 17
2017 5
2018 12
2019 7
2020 11
2021 13
2022 10
2023 10
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

816 results

Results by year

Filters applied: . Clear all
Page 1
Nefazodone.
[No authors listed] [No authors listed] 2020 Mar 6. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Mar 6. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643507 Free Books & Documents. Review.
Nefazodone is a serotoninergic modulating antidepressant that is used in therapy of depression, aggressive behavior and panic disorder. Nefazodone therapy has been associated with transient, usually asymptomatic elevations in serum aminotransferase levels and has be …
Nefazodone is a serotoninergic modulating antidepressant that is used in therapy of depression, aggressive behavior and panic disorde …
Nefazodone.
[No authors listed] [No authors listed] 2024 Jan 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Jan 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000248 Free Books & Documents. Review.
Limited information indicates that usual doses of nefazodone produce low but variable levels in milk that would not be expected to cause adverse effects in a breastfed infant, especially if the infant is older than 2 months. However, adverse effects in a breastfed preterm …
Limited information indicates that usual doses of nefazodone produce low but variable levels in milk that would not be expected to ca …
Nefazodone (Serzone).
[No authors listed] [No authors listed] 2023 Aug. Mother To Baby | Fact Sheets [Internet]. Brentwood (TN): Organization of Teratology Information Specialists (OTIS); 1994–. 2023 Aug. Mother To Baby | Fact Sheets [Internet]. Brentwood (TN): Organization of Teratology Information Specialists (OTIS); 1994–. PMID: 35952147 Free Books & Documents. Review.
This sheet is about exposure to nefazodone in pregnancy and while breastfeeding. This information is based on available published literature. ...
This sheet is about exposure to nefazodone in pregnancy and while breastfeeding. This information is based on available published lit …
Nefazodone: a new antidepressant.
Ellingrod VL, Perry PJ. Ellingrod VL, et al. Am J Health Syst Pharm. 1995 Dec 15;52(24):2799-812. doi: 10.1093/ajhp/52.24.2799. Am J Health Syst Pharm. 1995. PMID: 8748566 Review.
The chemistry, pharmacology, pharmacokinetics, and clinical efficacy of nefazodone hydrochloride, a new antidepressant, are described. Nefazodone enhances serotonin (5-hydroxytryptamine [5-HT]) synaptic transmission by acting as an antagonist at 5-HT2 receptors and …
The chemistry, pharmacology, pharmacokinetics, and clinical efficacy of nefazodone hydrochloride, a new antidepressant, are described …
Nefazodone: its place among antidepressants.
Cyr M, Brown CS. Cyr M, et al. Ann Pharmacother. 1996 Sep;30(9):1006-12. doi: 10.1177/106002809603000916. Ann Pharmacother. 1996. PMID: 8876863 Review.
Sedation, dry mouth, nausea, and dizziness are the more common adverse effects of nefazodone. Nefazodone, an analog of trazodone, has not been associated with priapism at this time, and may have fewer sexual adverse effects than other antidepressants. ...Nefazodo …
Sedation, dry mouth, nausea, and dizziness are the more common adverse effects of nefazodone. Nefazodone, an analog of trazodo …
Clinical pharmacokinetics of nefazodone.
Greene DS, Barbhaiya RH. Greene DS, et al. Clin Pharmacokinet. 1997 Oct;33(4):260-75. doi: 10.2165/00003088-199733040-00002. Clin Pharmacokinet. 1997. PMID: 9342502 Review.
Three pharmacologically active nefazodone metabolites have been identified: hydroxy-nefazodone, triazoledione and m-chlorophenylpiperazine (mCPP). ...Lower doses of nefazodone may be necessary in these groups. Nefazodone is a weak inhibitor of cytochro …
Three pharmacologically active nefazodone metabolites have been identified: hydroxy-nefazodone, triazoledione and m-chlorophen …
Nefazodone: An update.
Laizure SC, Cyr M. Laizure SC, et al. Int J Psychiatry Clin Pract. 2000;4(4):267-73. doi: 10.1080/13651500050517812. Int J Psychiatry Clin Pract. 2000. PMID: 24926576
Nefazodone is an antidepressant with some novel characteristics in regard to its putative mechanism of action. ...Recent reports indicate that nefazodone can cause severe hepatic toxicity. Evaluation of hepatic function before, and periodically after, therapy with …
Nefazodone is an antidepressant with some novel characteristics in regard to its putative mechanism of action. ...Recent reports indi …
Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.
Davis R, Whittington R, Bryson HM. Davis R, et al. Drugs. 1997 Apr;53(4):608-36. doi: 10.2165/00003495-199753040-00006. Drugs. 1997. PMID: 9098663 Review.
The optimum therapeutic dosage of nefazodone appears to be between 300 and 600 mg/day. Limited long term data suggest that nefazodone is effective in preventing relapse of depression in patients treated for up to 1 year. ...Nefazodone inhibits the cytochrome …
The optimum therapeutic dosage of nefazodone appears to be between 300 and 600 mg/day. Limited long term data suggest that nefazod …
The safety profile of nefazodone.
Robinson DS, Roberts DL, Smith JM, Stringfellow JC, Kaplita SB, Seminara JA, Marcus RN. Robinson DS, et al. J Clin Psychiatry. 1996;57 Suppl 2:31-8. J Clin Psychiatry. 1996. PMID: 8626361 Review.
Nefazodone treatment was associated with fewer side effects than were the control drugs. ...On the basis of the inhibition of cytochrome P450 3A4 isoenzyme by nefazodone in vitro, coadministration of terfenadine or astemizole with nefazodone is contraindicate …
Nefazodone treatment was associated with fewer side effects than were the control drugs. ...On the basis of the inhibition of cytochr …
Loratadine/nefazodone interaction.
Barbey JT. Barbey JT. Clin Pharmacol Ther. 2002 May;71(5):403; author reply 403. doi: 10.1067/mcp.2002.123945. Clin Pharmacol Ther. 2002. PMID: 12011827 No abstract available.
816 results